Both drugs were examined in the DoHH2 B-cell lymphoma flank xenograft model [103]
We talk through what this peptide is supposed to do, why its safety is still unclear and why more research is needed before those claims can be fully understood
[DOI] [PubMed] [Google Scholar] 126.Mody R, et al
In two studies with adults who had obesity and moderate to severe OSA over a 52-week period, participants who received Zepbound experienced a "statistically significant and clinically meaningful reduction" in episodes of shallow breathing or temporary pauses in breathing while asleep compared to those who received a placebo, the FDA said
10.1111/j.1471-4159.2006.03913.x 59
Their use must be assessed individually, taking into account existing medications, hormonal therapies, and overall health status